Biomechanical Impact of Phosphate Wasting on Articular Cartilage Using the Murine Hyp Model of X-linked hypophosphatemia

被引:0
作者
Macica, Carolyn M. [1 ,2 ,4 ]
Tommasini, Steven M. [3 ]
机构
[1] Connecticut Childrens Res Inst, Hartford, CT USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT USA
[3] Yale Univ, Dept Orthopaed & Rehabil, Sch Med, New Haven, CT USA
[4] Connecticut Childrens Res Inst, 10 Columbus Blvd, Hartford, CT 06106 USA
关键词
BIOMECHANICS; CELL/TISSUE SIGNALING - ENDOCRINE PATHWAYS; CHONDROCYTE AND CARTILAGE BIOLOGY; DISEASES AND DISORDERS OF/RELATED TO BONE; DISORDERS OF CALCIUM/PHOSPHATE METABOLISM; ARTICULAR CARTILAGE; ORTHOPAEDICS; OSTEOARTHRITIS; PTH/Vit D/FGF23; SUBCHONDRAL BONE; MECHANICAL-PROPERTIES; CALCIFIED CARTILAGE; COLLAGEN; MOUSE; OSTEOARTHRITIS; BEHAVIOR; QUALITY; TENSION; JOINTS;
D O I
10.1002/jbm4.10796
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Degenerative osteoarthritis (OA) is recognized as an early-onset comorbidity of X-linked hypophosphatemia (XLH), contributing to pain and stiffness and limiting range of motion and activities of daily living. Here, we extend prior findings describing biochemical and cellular changes of articular cartilage (AC) in the phosphate-wasting environment of XLH to determine the impact of these changes on the biomechanical properties of AC in compression and potential role in the etiology of OA. We hypothesize that despite increased proteoglycan biosynthesis, disruption of the mineralized zone of AC impacts the mechanical properties of cartilage that function to accommodate loads and that therapeutic restoration of this zone will improve the mechanical properties of AC. Data were compared between three groups: wild type (WT), Hyp, and Hyp mice treated with calcitriol and oral phosphate. EPIC microCT confirmed AC mineral deficits and responsiveness to therapy. MicroCT of the Hyp subchondral bone plate revealed that treatment improved trabecular bone volume (BV/TV) but remained significantly lower than WT mice in other trabecular microstructures (p < 0.05). Microindentation AC studies revealed that, compared with WT mice, the mean stiffness of tibial AC was significantly lower in untreated Hyp mice (2.65 +/- 0.95 versus 0.87 +/- 0.33 N/mm, p < 0.001) and improved with therapy (2.15 + 0.38 N/mm) to within WT values. Stress relaxation of AC under compressive loading displayed similar biphasic relaxation time constants (Taufast and Tauslow) between controls and Hyp mice, although Tauslow trended toward slowed relaxation times. In addition, Taufast and Tauslow times correlated with peak load in WT mice (r = 0.80; r = 0.78, respectively), whereas correlation coefficient values for Hyp mice (r = 0.46; r = 0.21) improved with treatment (r = 0.71; r = 0.56). These data provide rationale for therapies that both preserve AC stiffness and recovery from compression. The Hyp mouse also provides unique insight into determinants of structural stiffness and the viscoelastic properties of AC in the progression of OA. (c) 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
引用
收藏
页数:11
相关论文
共 52 条
  • [1] A framework for the in vivo pathomechanics of osteoarthritis at the knee
    Andriacchi, TP
    Mündermann, A
    Smith, RL
    Alexander, EJ
    Dyrby, CO
    Koo, S
    [J]. ANNALS OF BIOMEDICAL ENGINEERING, 2004, 32 (03) : 447 - 457
  • [2] [Anonymous], 2014, BURDEN MUSCULOSKELET, VThird
  • [3] FGF23 and its role in X-linked hypophosphatemia-related morbidity
    Beck-Nielsen, Signe Sparre
    Mughal, Zulf
    Haffner, Dieter
    Nilsson, Ola
    Levtchenko, Elena
    Ariceta, Gema
    Collantes, Carmen de Lucas
    Schnabel, Dirk
    Jandhyala, Ravi
    Makitie, Outi
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [4] Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension
    Briot, Karine
    Portale, Anthony A.
    Brandi, Maria Luisa
    Carpenter, Thomas O.
    Cheong, Hae Ii
    Cohen-Solal, Martine
    Crowley, Rachel K.
    Eastell, Richard
    Imanishi, Yasuo
    Ing, Steven
    Insogna, Karl
    Ito, Nobuaki
    Jan de Beur, Suzanne
    Javaid, Muhammad K.
    Kamenicky, Peter
    Keen, Richard
    Kubota, Takuo
    Lachmann, Robin H.
    Perwad, Farzana
    Pitukcheewanont, Pisit
    Ralston, Stuart H.
    Takeuchi, Yasuhiro
    Tanaka, Hiroyuki
    Weber, Thomas J.
    Yoo, Han-Wook
    Nixon, Annabel
    Nixon, Mark
    Sun, Wei
    Williams, Angela
    Imel, Erik A.
    [J]. RMD OPEN, 2021, 7 (03):
  • [5] BROOM ND, 1982, J ANAT, V135, P65
  • [6] Increased Bone Volume and Correction of HYP Mouse Hypophosphatemia in the Klotho/HYP Mouse
    Brownstein, Catherine A.
    Zhang, Junhui
    Stillman, Althea
    Ellis, Bruce
    Troiano, Nancy
    Adams, Douglas J.
    Gundberg, Caren M.
    Lifton, Richard P.
    Carpenter, Thomas O.
    [J]. ENDOCRINOLOGY, 2010, 151 (02) : 492 - 501
  • [7] Impact of Early Conventional Treatment on Adult Bone and Joints in a Murine Model of X-Linked Hypophosphatemia
    Cauliez, Axelle
    Zhukouskaya, Volha V.
    Hilliquin, Stephane
    Sadoine, Jeremy
    Slimani, Lotfi
    Miceli-Richard, Corinne
    Briot, Karine
    Linglart, Agnes
    Chaussain, Catherine
    Bardet, Claire
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [8] Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms
    Che, Helene
    Roux, Christian
    Etcheto, Adrien
    Rothenbuhler, Anya
    Kamenicky, Peter
    Linglart, Agnes
    Briot, Karine
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (03) : 325 - 333
  • [9] Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations
    Chesher, Douglas
    Oddy, Michael
    Darbar, Ulpee
    Sayal, Parag
    Casey, Adrian
    Ryan, Aidan
    Sechi, Annalisa
    Simister, Charlotte
    Waters, Aoife
    Wedatilake, Yehani
    Lachmann, Robin H.
    Murphy, Elaine
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (05) : 865 - 876
  • [10] Eerola I, 1998, ARTHRITIS RHEUM-US, V41, P1287, DOI 10.1002/1529-0131(199807)41:7<1287::AID-ART20>3.0.CO